AAF on Fifth Circuit Decision on Mifepristone

August 16, 2023

Advancing American Freedom issued the following statement after the Fifth Circuit’s decision to reinstitute restrictions that the Food and Drug Administration (FDA) had lifted in recent years.

“The FDA’s initial approval of mifepristone should remain under scrutiny; it should not have been approved,” said J. Marc Wheat, General Counsel for AAF. “We applaud that the Fifth Circuit has recognized that an abortion drug that has been recorded to have dangerous side effects should not have safety restrictions requiring physician care for its use stripped by FDA. The Fifth Circuit’s opinion cited a declaration that a woman nine weeks pregnant had been treated by hospital staff for a pulmonary embolism with anti-coagulants; yet Planned Parenthood of Indiana gave her mifepristone. Had she not been taken to a hospital afterward, the chemical abortion could have caused her to bleed out and die. Advancing American Freedom will continue to stand for the protection and safety of women and the unborn.”